Immunologic Response Elicited in Breast Cancer Patients Receiving a NeuGcGM3-based Vaccine as Adjuvant Therapy

Article

Abstract: This study aimed to investigate the immunogenicity of a cancer vaccine consisting of the NeuGcGM3 ga

Palabras claves:

adjuvant therapy, Breast Cancer, cytotoxic antibodies, Ganglioside, NeuGcGM3, Vaccine

Autores:

Curbelo I., Estevez A., Fernandez L.E., Gonzalez Z., Luaces P.L.o., Mazorra Z., Mulens V., Pérez K., Rubio M.C., Tania Crombet, Valdes-Zayas A., Vega A.M.

Fuentes:

scopus